We are live on ! Find out more
MD icon

Pediatrix Medical

304 hedge funds and large institutions have $5.49B invested in Pediatrix Medical in 2013 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 104 increasing their positions, 121 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 18

106% more call options, than puts

Call options by funds: $29M | Put options by funds: $14M

10% more funds holding

Funds holding: 276304 (+28)

9% more capital invested

Capital invested by funds: $5.05B → $5.49B (+$437M)

14% less repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 121

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

98.63% less ownership

Funds ownership: 201%102.38% (-99%)

Holders
304
Holders Change
+28
Holders Change %
+10.14%
% of All Funds
8.82%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.15%
New
48
Increased
104
Reduced
121
Closed
18
Calls
$29M
Puts
$14M
Net Calls
+$14.9M
Net Calls Change
+$19.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$449M -$57.1M -1,064,540 -11%
Vanguard Group
2
Vanguard Group
Pennsylvania
$315M +$10.9M +203,150 +4%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$298M +$1.03M +19,100 +0.3%
Bank of New York Mellon
4
Bank of New York Mellon
New York
$260M -$3.92M -73,034 -1%
FCM
5
Frontier Capital Management
Massachusetts
$248M -$32.6M -608,242 -12%
CPCM
6
Clifton Park Capital Management
Delaware
$238M
1832 Asset Management
7
1832 Asset Management
Ontario, Canada
$199M +$1.21M +22,600 +0.6%
BFA
8
BlackRock Fund Advisors
California
$158M +$13.3M +248,609 +9%
BIT
9
BlackRock Institutional Trust
California
$147M +$5.19M +96,703 +4%
State Street
10
State Street
Massachusetts
$140M -$5.76M -107,409 -4%
EARNEST Partners
11
EARNEST Partners
Georgia
$133M +$134M +2,494,850 New
RP
12
Riverbridge Partners
Minnesota
$130M +$13.7M +255,189 +12%
AllianceBernstein
13
AllianceBernstein
Tennessee
$106M +$1.41M +26,198 +1%
WA
14
Wasatch Advisors
Utah
$103M -$1.42M -26,389 -1%
Lord, Abbett & Co
15
Lord, Abbett & Co
New Jersey
$102M -$13.9M -258,342 -12%
ClearBridge Investments
16
ClearBridge Investments
New York
$83.2M +$2.42M +45,096 +3%
WHG
17
Westwood Holdings Group
Texas
$79.8M -$5.41M -100,891 -6%
Goldman Sachs
18
Goldman Sachs
New York
$70M +$4.18M +77,931 +6%
Invesco
19
Invesco
Georgia
$69.3M +$41.9K +781 +0.1%
Wellington Management Group
20
Wellington Management Group
Massachusetts
$66.9M +$66.4M +1,237,640 +7,735%
FAM
21
Fenimore Asset Management
New York
$65.4M -$138K -2,575 -0.2%
Robeco Institutional Asset Management
22
Robeco Institutional Asset Management
Netherlands
$64.6M -$4M -74,596 -6%
William Blair & Company
23
William Blair & Company
Illinois
$64.3M +$48.3M +900,153 +295%
RA
24
Royce & Associates
New York
$57M -$24M -446,600 -29%
TCM
25
TimesSquare Capital Management
New York
$54.5M -$3.14M -58,600 -5%

MD Hedge Fund Activity: Q4 2013 in Review

304 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2013, worth a combined $5.49B — up 8.7% from $5.05B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new MD positions and 18 closed out — a net gain of 30 holders — while 104 added to existing stakes and 121 trimmed.

The largest buyer was EARNEST Partners, opening a new position worth an estimated $134M. The largest seller was Fidelity Investments, cutting an estimated $57.1M.

  • 304 institutional investors held Pediatrix Medical (MD) as of Q4 2013, up from 276 in Q3 2013.
  • Funds reported $5.49B of Pediatrix Medical stock for Q4 2013, up 8.7% quarter-over-quarter.
  • 48 funds opened new Pediatrix Medical positions in Q4 2013 and 18 closed out, a net change of +30 holders.
  • The largest Pediatrix Medical buyer in Q4 2013 was EARNEST Partners, an estimated $134M added.
  • The largest Pediatrix Medical seller in Q4 2013 was Fidelity Investments, an estimated $57.1M sold.

Based on aggregated 13F filings for Q4 2013.